Growth Metrics

Burning Rock Biotech (BNR) Current Assets (2020 - 2025)

Historic Current Assets for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $103.9 million.

  • Burning Rock Biotech's Current Assets fell 714.39% to $103.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $103.9 million, marking a year-over-year decrease of 714.39%. This contributed to the annual value of $106.4 million for FY2024, which is 1455.63% down from last year.
  • Per Burning Rock Biotech's latest filing, its Current Assets stood at $103.9 million for Q3 2025, which was down 714.39% from $103.4 million recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's Current Assets ranged from a high of $556.2 million in Q4 2021 and a low of $103.4 million during Q2 2025
  • Its 5-year average for Current Assets is $198.2 million, with a median of $150.3 million in 2023.
  • In the last 5 years, Burning Rock Biotech's Current Assets skyrocketed by 4380.99% in 2021 and then crashed by 6718.81% in 2022.
  • Burning Rock Biotech's Current Assets (Quarter) stood at $556.2 million in 2021, then tumbled by 67.19% to $182.5 million in 2022, then tumbled by 31.77% to $124.5 million in 2023, then dropped by 14.56% to $106.4 million in 2024, then dropped by 2.39% to $103.9 million in 2025.
  • Its Current Assets stands at $103.9 million for Q3 2025, versus $103.4 million for Q2 2025 and $104.9 million for Q1 2025.